Navigation Links
Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
Date:12/8/2012

COLUMBUS, Ohio Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.

The agent, ibrutinib (PCI-32765), is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential for CLL-cell survival and proliferation. CLL is the most common form of leukemia, with about 15,000 new cases annually in the U.S. About 4,400 Americans die of the disease each year.

Study co-leader Dr. John C. Byrd, director of the division of hematology at Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James) presented these findings today (12/8) at the 54th Annual Meeting of the American Society of Hematology (ASH) Annual Meeting in Atlanta, GA.

The study found that response to therapy was high across cohorts, with 71 percent of previously untreated older patients experiencing a complete or partial response at either treatment dose (420mg and 840mg). The same response was observed in 67 percent of the relapsed patients and half (50%) of the high-risk patient cohort. After 22 months of follow-up, the disease had not progressed in 96 percent of previously untreated patients and 76 percent of relapsed and high-risk patients.

"These findings are truly exciting because they demonstrate ibrutinib's potential as a highly active, well-tolerated first-line therapy for CLL that produces a high rate of durable remissions the remissions last months on end," Byrd says. "The drug is effective in part because patients are willing to stay on treatment since the side effects are very tolerable," he states.

Only non-severe side effects, including diarrhea, fatigue, chest infection, rash, nausea, joint pain and infrequent and transient low blood counts were observed. Investigators found no evidence of c
'/>"/>

Contact: Liz Bryan, Spectrum
lbryan@spectrumscience.com
443-506-1931
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. EzCheckPrinting Updated with New Category Feature to Simplify Check Printing and Tax Reporting
2. Winning the battle against leukaemia: Positive early results in clinical trial for DNA vaccine
3. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
4. USC Norris cancer research ranks among top clinical advances for 2012
5. American Society of Clinical Oncology issues annual report on state of clinical cancer science
6. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
7. Study finds link between access to online health information and use of clinical services
8. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
9. Molecular portraits of tumours match patients with trials in everyday clinical practice
10. New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
11. Spread of human melanoma cells in mice correlates with clinical outcomes in patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Good Neighbor Community Services ... upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this segment, ... Services’ vision to redefine the traditional approach to ... services. Through passion, innovation, determination, excellence, and collaboration, ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 SF ... accessories at the lowest prices on the internet with ... Cables in two lengths and two colors. These lightning ... standards. , The high quality SF Cable ... connector with digital signal delivering faster charging and syncing. ...
(Date:7/30/2014)... July 30, 2014 Hamilton Facial ... of its new Carmel office on July 30th. After ... finally be moving to the state-of-the-art suite, located only ... innovative space will allow for one-on-one patient comfort, shorter ... experience. , Dr. Hamilton’s new office-suite will continue ...
(Date:7/30/2014)... ... ... ... , UCLA ... For the study, published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. ...
(Date:7/30/2014)... 2014 As the controversy surrounding the ... surgeries continues to grow, Bernstein Liebhard LLP notes that ... for a ban on uterine morcellation. According to a ... with leiomyosarcoma following a hysterectomy that involved the use ... diagnosis, the aggressive cancer had progressed to Stage 4. ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
... put in their,current Medicare prescription drug plans, the ... monthly premiums for 2008, says new analysis,released by ... and its proprietary DataFrame(R),database, Avalere experts computed an ... marketplace. Under this method, the premiums of,plans with ...
... Denying Right, to Fly; Case Could Set Precedent for Airline Travel Rights ... ... Oct. 5 A 26-year-old disabled man,who was denied access to a ... Andy Gates is affected by dystonia, an obscure neuromuscular movement,disorder that causes ...
... two,studies comparing colorectal cancer screening by conventional or ... sparked interest in colorectal cancer screening and may ... one a large multi-center,trial sponsored by the NIH ... of Wisconsin published in the New England Journal ...
... good for the heart, researchers say , , FRIDAY, Oct. 5 ... according to a study ranking eight popular weight-loss programs. , ... better than those with a heavy protein focus. , The ... potential to prevent heart disease risk factors. The Atkins diet ...
... to Acquire Groundbreaking Tool, AUSTIN, Texas, Oct. 5 ... a new robotic surgery system that allows for,minimally invasive ... a,stroke. Called the Sensei(TM) Robotic Catheter System and Artisan(TM),Control ... be installed in,the country after the Cleveland Clinic. ...
... support,service provider Healthways is opening its first service ... Nashville, Tennessee,will employ 100 workers in the short-term ... the medium term. "Healthways, decision to open ... success for both the town and the state ...
Cached Medicine News:Health News:Average Medicare Prescription Drug Premiums to Rise 21% 2Health News:Major US Airline Discriminates Against Disabled Passenger, Lawsuit Charges 2Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 2Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 3Health News:Study Rates Heart Health of Popular Diet Plans 2Health News:Study Rates Heart Health of Popular Diet Plans 3Health News:Study Rates Heart Health of Popular Diet Plans 4Health News:St. David's Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 2Health News:St. David's Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3Health News:Healthways Enters German Healthcare Market 2
(Date:7/30/2014)... 30, 2014 Research and Markets has announced ... Forecasts to 2019" report to their offering. ... to grow at a lower CAGR in developed countries; however, it ... China , India , and ... The growth of the hematology analyzers and reagents market is ...
(Date:7/30/2014)... July 30, 2014 Reportlinker.com announces that ... its catalogue: mHealth and Home Monitoring ... Executive summary mHealth ... to better outcomes, decreased costs and improved sustainability ... solutions is still in an early stage, but ...
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
Breaking Medicine Technology:Hematology Analyzers & Reagents Market - Forecasts to 2019 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3
... 2012  Common practices for changing from one opioid to another, ... to the growing number of opioid-related fatalities, new research suggests. ... study using this new model of opioid rotation are presented ... official journal of the American Academy of Pain Medicine (AAPM). ...
...  Aided by the launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) ... 16.3% in 2011 to become the fastest growing category on ... Drugs USA 2011 report by international consulting and research ... market posted a gain of 2.4% reaching $21.4 billion in 2011 ...
Cached Medicine Technology:Research Finds Overdose Deaths Occur When Changing Opioids 2Research Finds Overdose Deaths Occur When Changing Opioids 3Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 2Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 3
... several different two-stage, oil-sealed, rotary vane vacuum ... applications. Each pump comes complete with a ... and Oil Mist Filter (EMF-10). The GBORK ... ballast to keep the oil clean without ...
... is perfect for electrophoresis gel drying, and ... of greater than 29 inches of mercury ... with the Model 583 gel dryer. Includes: ... and 3/8 inch ID vacuum tubing, vacuum ...
Variable Speed Pump...
Inquire...
Medicine Products: